,i #aahth ,,congress #b;d ,session ,h4 ,r4 #gcab ,,in ,,the ,,house ,,of ,,representatives ,february #i1 #bjbd,ms4 ,kuster 7for herself1 ,mr4 ,balderson1 and ,ms4 ,letlow7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce1 and in addition to the ,committees on ,education and the ,workforce1 ,ways and ,means1 and the ,judiciary1 for a period to be subsequently determined by the ,speaker1 in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned ,a ,,bill ,to provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage4 #a4 ,short title ,this ,act may be cited as the ,electronic ,prescribing for ,controlled ,substances ,act or the ,,epcs #b4j ,act4 #b4 ,requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage 7a7 ,public ,health ,service ,act amendment ,section #bgii;,a-#g of the ,public ,health ,service ,act 7#db ,u4,s4,c4 #cjj;gg-#aag7 is amended by adding at the end the following new subsection3 7d7 ,requirements for electronic-,prescribing for controlled substances 7#a7 ,in general ,except as provided pursuant to paragraph 7#b71 for plan years beginning on or after ,january #a1 #bjbf1 a group health plan and a health insurance issuer offering group or individual health insurance coverage1 with respect to a participating provider1 as defined in section #bgii-a7;a77#c71 shall have in place policies1 subject to paragraphs 7#d7 and 7#e71 that require any prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance 7as defined by section #bjb of the ,controlled ,substances ,act7 covered by the plan or coverage that is transmitted by such a participating provider for such a participant1 beneficiary1 or enrollee be electronically transmitted consistent with standards established under paragraph 7#c7 of section #ahfj;,d-#d7;e7 of the ,social ,security ,act1 under an electronic prescription drug program that meets requirements that are substantially similar 7as jointly determined by the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury7 to the requirements of paragraph 7#b7 of such section #ahfj;,d-#d7;e74 7#b7 ,exception for certain circumstances ,the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury shall jointly1 through rulemaking1 specify circumstances and processes by which the requirement under paragraph 7#a7 may be waived1 with respect to a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health plan or group or individual health insurance coverage offered by a health insurance issuer1 including in the case of-- 7,a7 a prescription issued when the participating provider and dispensing pharmacy are the same entity2 7,b7 a prescription issued that cannot be transmitted electronically under the most recently implemented version of the ,national ,council for ,prescription ,drug ,programs ,,script ,standard2 7,c7 a prescription issued by a participating provider who received a waiver 7which may include a waiver obtained pursuant to section #ahfj;,d-#d7;e77#g77;,b77iii7 of the ,social ,security ,act7 or a renewal thereof for a period of time as determined by the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury1 not to exceed one year1 from the requirement to use electronic prescribing due to demonstrated economic hardship1 technological limitations that are not reasonably within the control of the participating provider1 or other exceptional circumstance demonstrated by the participating provider2 7,d7 a prescription issued by a participating provider under circumstances in which1 notwithstanding the participating provider's ability to submit a prescription electronically as required by this subsection1 such participating provider reasonably determines that it would be impractical for the individual involved to obtain substances prescribed by electronic prescription in a timely manner1 and such delay would adversely impact the individual's medical condition involved2 7,e7 a prescription issued by a participating provider prescribing a drug under a research protocol2 7,f7 a prescription issued by a participating provider for a drug for which the ,food and ,drug ,administration requires a prescription to contain elements that are not able to be included in electronic prescribing1 such as a drug with risk evaluation and mitigation strategies that include elements to assure safe use2 7,g7 a prescription issued for an individual who receives hospice care or for a resident of a nursing facility 7as defined in section #aiai7;a7 of the ,social ,security ,act72 7,h7 a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure1 as specified jointly by the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury through rulemaking2 and 7,i7 a prescription issued by a participating provider allowing for the dispensing of a non-patient specific prescription pursuant to a standing order1 approved protocol for drug therapy1 collaborative drug management1 or comprehensive medication management1 in response to a public health emergency or other circumstances under which the participating provider may issue a non-patient specific prescription4 7#c7 ,rules of ,construction 7,a7 ,verification ,nothing in this subsection shall be construed as requiring a dispenser to verify that a participating provider1 with respect to a prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health plan or group or individual health insurance coverage offered by a health insurance issuer1 has a waiver 7or is otherwise exempt7 under paragraph 7#b7 from the requirement under paragraph 7#a74 7,b7 ,authority to dispense ,nothing in this subsection shall be construed as affecting the authority of a group health plan or group or individual health insurance coverage offered by a health insurance issuer to cover1 or the authority of a dispenser to continue to dispense1 a prescription drug if the prescription for such drug is an otherwise valid written1 oral1 or fax prescription that is consistent with applicable law4 7,c7 ,patient choice ,nothing in this subsection shall be construed as affecting the ability of an individual who is a participant1 beneficiary1 or enrollee of a group health plan or group or individual health insurance coverage offered by a health insurance issuer and who is prescribed a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by the plan or coverage to designate a particular dispenser to dispense a prescribed controlled substance to the extent consistent with the requirements under this subsection4 7#d7 ,regulations on policy requirements ,the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury shall promulgate regulations specifying requirements for the policies established by group health plans and health insurance issuers under paragraph 7#a74 ,such regulations shall include requirements for-- 7,a7 a uniform process by which plans and issuers are required to set the e-prescribing requirements2 7,b7 a process by which plans and issuers are required to grant waivers and exceptions to participating providers pursuant to paragraph 7#b72 and 7,c7 a mechanism for plans and issuers to recognize waivers issued to participating providers under part ,d of title ,,xviii of the ,social ,security ,act1 pursuant to paragraph 7#b77;,c74 7#e7 ,prohibitions ,the policies established pursuant to paragraph 7#a7 by a group health plan or health insurance issuer offering group or individual health insurance coverage may not-- 7,a7 require dispensers of a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance to confirm that the prescription for the controlled substance was electronically issued by a participating provider in accordance with such policies1 as described in paragraph 7#a72 7,b7 require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a participating provider's compliance with such policies2 7,c7 reject1 deny1 or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued2 or 7,d7 require a participating provider to use a specific vendor for electronic prescribing or a specific electronic prescribing product or system4 7#f7 ,attestation of compliance ,beginning on ,january #a1 #bjbf1 each group health plan and health insurance issuer offering group or individual health insurance coverage shall annually submit to the ,secretary1 the ,secretary of ,labor1 and the ,secretary of the ,treasury an attestation of compliance with the requirements of this subsection4 7#g7 ,consultation requirement for rulemaking ,in promulgating regulations to carry out this subsection1 the ,secretary1 the ,secretary of the ,labor1 and the ,secretary of the ,treasury shall jointly consult with dispensers of controlled substances1 ,state insurance regulators1 health insurance issuers offering group or individual health insurance coverage1 and health care practitioners4 4 7b7 ,employee ,retirement ,income ,security ,act of #aigd amendment ,section #gbb of the ,employee ,retirement ,income ,security ,act of #aigd 7#bi ,u4,s4,c4 #aahek7 is amended by adding at the end the following new subsection3 7d7 ,requirements for electronic-,prescribing for controlled substances 7#a7 ,in general ,except as provided pursuant to paragraph 7#b71 for plan years beginning on or after ,january #a1 #bjbf1 a group health plan and a health insurance issuer offering group health insurance coverage1 with respect to a participating provider1 as defined in section #gaf7;a77#c71 shall have in place policies1 subject to paragraphs 7#d7 and 7#e71 that require any prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance 7as defined by section #bjb of the ,controlled ,substances ,act7 covered by the plan or coverage that is transmitted by such a participating provider for such a participant or beneficiary be electronically transmitted consistent with standards established under paragraph 7#c7 of section #ahfj;,d-#d7;e7 of the ,social ,security ,act1 under an electronic prescription drug program that meets requirements that are substantially similar 7as jointly determined by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury7 to the requirements of paragraph 7#b7 of such section #ahfj;,d-#d7;e74 7#b7 ,exception for certain circumstances ,the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury shall jointly1 through rulemaking1 specify circumstances and processes by which the requirement under paragraph 7#a7 may be waived1 with respect to a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health plan or group health insurance coverage offered by a health insurance issuer1 including in the case of-- 7,a7 a prescription issued when the participating provider and dispensing pharmacy are the same entity2 7,b7 a prescription issued that cannot be transmitted electronically under the most recently implemented version of the ,national ,council for ,prescription ,drug ,programs ,,script ,standard2 7,c7 a prescription issued by a participating provider who received a waiver 7which may include a waiver obtained pursuant to section #ahfj;,d-#d7;e77#g77;,b77iii7 of the ,social ,security ,act7 or a renewal thereof for a period of time as determined by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury1 not to exceed one year1 from the requirement to use electronic prescribing due to demonstrated economic hardship1 technological limitations that are not reasonably within the control of the participating provider1 or other exceptional circumstance demonstrated by the participating provider2 7,d7 a prescription issued by a participating provider under circumstances in which1 notwithstanding the participating provider's ability to submit a prescription electronically as required by this subsection1 such participating provider reasonably determines that it would be impractical for the individual involved to obtain substances prescribed by electronic prescription in a timely manner1 and such delay would adversely impact the individual's medical condition involved2 7,e7 a prescription issued by a participating provider prescribing a drug under a research protocol2 7,f7 a prescription issued by a participating provider for a drug for which the ,food and ,drug ,administration requires a prescription to contain elements that are not able to be included in electronic prescribing1 such as a drug with risk evaluation and mitigation strategies that include elements to assure safe use2 7,g7 a prescription issued for an individual who receives hospice care or for a resident of a nursing facility 7as defined in section #aiai7;a7 of the ,social ,security ,act72 7,h7 a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure1 as specified jointly by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury through rulemaking2 and 7,i7 a prescription issued by a participating provider allowing for the dispensing of a non-patient specific prescription pursuant to a standing order1 approved protocol for drug therapy1 collaborative drug management1 or comprehensive medication management1 in response to a public health emergency or other circumstances under which the participating provider may issue a non-patient specific prescription4 7#c7 ,rules of ,construction 7,a7 ,verification ,nothing in this subsection shall be construed as requiring a dispenser to verify that a participating provider1 with respect to a prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health plan or group or individual health insurance coverage offered by a health insurance issuer1 has a waiver 7or is otherwise exempt7 under paragraph 7#b7 from the requirement under paragraph 7#a74 7,b7 ,authority to dispense ,nothing in this subsection shall be construed as affecting the authority of a group health plan or group health insurance coverage offered by a health insurance issuer to cover1 or the authority of a dispenser to continue to dispense1 a prescription drug if the prescription for such drug is an otherwise valid written1 oral1 or fax prescription that is consistent with applicable law4 7,c7 ,patient choice ,nothing in this subsection shall be construed as affecting the ability of an individual who is a participant or beneficiary of a group health plan or group or individual health insurance coverage offered by a health insurance issuer and who is prescribed a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by the plan or coverage to designate a particular dispenser to dispense a prescribed controlled substance to the extent consistent with the requirements under this subsection4 7#d7 ,regulations on policy requirements ,the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury shall promulgate regulations specifying requirements for the policies established by group health plans and health insurance issuers under paragraph 7#a74 ,such regulations shall include requirements for-- 7,a7 a uniform process by which plans and issuers are required to set the e-prescribing requirements2 7,b7 a process by which plans and issuers are required to grant waivers and exceptions to participating providers pursuant to paragraph 7#b72 and 7,c7 a mechanism for plans and issuers to recognize waivers issued to participating providers under part ,d of title ,,xviii of the ,social ,security ,act1 pursuant to paragraph 7#b77;,c74 7#e7 ,prohibitions ,the policies established pursuant to paragraph 7#a7 by a group health plan or health insurance issuer offering group health insurance coverage may not-- 7,a7 require dispensers of a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance to confirm that the prescription for the controlled substance was electronically issued by a participating provider in accordance with such policies1 as described in paragraph 7#a72 7,b7 require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a participating provider's compliance with such policies2 7,c7 reject1 deny1 or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued2 or 7,d7 require a participating provider to use a specific vendor for electronic prescribing or a specific electronic prescribing product or system4 7#f7 ,attestation of compliance ,beginning on ,january #a1 #bjbf1 each group health plan and health insurance issuer offering group health insurance coverage shall annually submit to the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury an attestation of compliance with the requirements of this subsection4 7#g7 ,consultation requirement for rulemaking ,in promulgating regulations to carry out this subsection1 the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of the ,treasury shall jointly consult with dispensers of controlled substances1 ,state insurance regulators1 health insurance issuers offering group or individual health insurance coverage1 and health care practitioners4 4 7c7 ,internal ,revenue ,code of #aihf amendment ,section #ihbb of the ,internal ,revenue ,code of #aihf is amended by adding at the end the following new subsection3 7d7 ,requirements for electronic-,prescribing for controlled substances 7#a7 ,in general ,except as provided pursuant to paragraph 7#b71 for plan years beginning on or after ,january #a1 #bjbf1 a group health plan1 with respect to a participating provider1 as defined in section #ihaf7;a77#c71 shall have in place policies1 subject to paragraphs 7#d7 and 7#e71 that require any prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance 7as defined by section #bjb of the ,controlled ,substances ,act7 covered by the plan that is transmitted by such a participating provider for such a participant or beneficiary be electronically transmitted consistent with standards established under paragraph 7#c7 of section #ahfj;,d-#d7;e7 of the ,social ,security ,act1 under an electronic prescription drug program that meets requirements that are substantially similar 7as jointly determined by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor7 to the requirements of paragraph 7#b7 of such section #ahfj;,d-#d7;e74 7#b7 ,exception for certain circumstances ,the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor shall jointly1 through rulemaking1 specify circumstances and processes by which the requirement under paragraph 7#a7 may be waived1 with respect to a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health1 including in the case of-- 7,a7 a prescription issued when the participating provider and dispensing pharmacy are the same entity2 7,b7 a prescription issued that cannot be transmitted electronically under the most recently implemented version of the ,national ,council for ,prescription ,drug ,programs ,,script ,standard2 7,c7 a prescription issued by a participating provider who received a waiver 7which may include a waiver obtained pursuant to section #ahfj;,d-#d7;e77#g77;,b77iii7 of the ,social ,security ,act7 or a renewal thereof for a period of time as determined by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor1 not to exceed one year1 from the requirement to use electronic prescribing due to demonstrated economic hardship1 technological limitations that are not reasonably within the control of the participating provider1 or other exceptional circumstance demonstrated by the participating provider2 7,d7 a prescription issued by a participating provider under circumstances in which1 notwithstanding the participating provider's ability to submit a prescription electronically as required by this subsection1 such participating provider reasonably determines that it would be impractical for the individual involved to obtain substances prescribed by electronic prescription in a timely manner1 and such delay would adversely impact the individual's medical condition involved2 7,e7 a prescription issued by a participating provider prescribing a drug under a research protocol2 7,f7 a prescription issued by a participating provider for a drug for which the ,food and ,drug ,administration requires a prescription to contain elements that are not able to be included in electronic prescribing1 such as a drug with risk evaluation and mitigation strategies that include elements to assure safe use2 7,g7 a prescription issued for an individual who receives hospice care or for a resident of a nursing facility 7as defined in section #aiai7;a7 of the ,social ,security ,act72 7,h7 a prescription issued under circumstances in which electronic prescribing is not available due to temporary technological or electrical failure1 as specified jointly by the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor through rulemaking2 and 7,i7 a prescription issued by a participating provider allowing for the dispensing of a non-patient specific prescription pursuant to a standing order1 approved protocol for drug therapy1 collaborative drug management1 or comprehensive medication management1 in response to a public health emergency or other circumstances under which the participating provider may issue a non-patient specific prescription4 7#c7 ,rules of ,construction 7,a7 ,verification ,nothing in this subsection shall be construed as requiring a dispenser to verify that a participating provider1 with respect to a prescription for a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by a group health plan1 has a waiver 7or is otherwise exempt7 under paragraph 7#b7 from the requirement under paragraph 7#a74 7,b7 ,authority to dispense ,nothing in this subsection shall be construed as affecting the ability of a group health plan to cover1 or the ability of a dispenser to continue to dispense1 a prescription drug if the prescription for such drug is an otherwise valid written1 oral1 or fax prescription that is consistence with applicable laws and regulations4 7,c7 ,patient choice ,nothing in this subsection shall be construed as affecting the ability of an individual who is a participant or beneficiary of a group health plan and who is prescribed a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance that is a prescription drug covered by the plan to designate a particular dispenser to dispense a prescribed controlled substance to the extent consistent with the requirements under this subsection4 7#d7 ,regulations on policy requirements ,the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor shall promulgate regulations specifying requirements for the policies established by group health plans under paragraph 7#a74 ,such regulations shall include requirements for-- 7,a7 a uniform process by which plans are required to set the e-prescribing requirements2 7,b7 a process by which plans are required to grant waivers and exceptions to participating providers pursuant to paragraph 7#b72 and 7,c7 a mechanism for plans to recognize waivers issued to participating providers under part ,d of title ,,xviii of the ,public ,health ,service ,act1 pursuant to paragraph 7#b77;,c74 7#e7 ,prohibitions ,the policies established pursuant to paragraph 7#a7 by a group health plan may not-- 7,a7 require dispensers of a schedule ,,ii1 ,,iii1 ,,iv1 or ,v controlled substance to confirm that the prescription for the controlled substance was electronically issued by a participating provider in accordance with such policies1 as described in paragraph 7#a72 7,b7 require dispensers of such controlled substances to submit information or data beyond what is otherwise required to process a prescription drug claim in order to confirm a participating provider's compliance with such policies2 7,c7 reject1 deny1 or recoup reimbursement for a prescription drug claim based on the format in which the prescription was issued2 or 7,d7 require a participating provider to use a specific vendor for electronic prescribing or a specific electronic prescribing product or system4 7#f7 ,attestation of compliance ,beginning on ,january #a1 #bjbf1 each group health plan shall annually submit to the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor an attestation of compliance with the requirements of this subsection4 7#g7 ,consultation requirement for rulemaking ,in promulgating regulations to carry out this subsection1 the ,secretary1 the ,secretary of ,health and ,human ,services1 and the ,secretary of ,labor shall jointly consult with dispensers of controlled substances1 ,state insurance regulators1 health insurance issuers offering group or individual health insurance coverage1 and health care practitioners4 4 7d7 ,update of biometric component of multifactor authentication ,not later than #a year after the date of enactment of this ,act1 the ,attorney ,general shall finalize a regulation updating the requirements for the biometric component of multifactor authentication with respect to electronic prescriptions of controlled substances1 as required under section #bjjc7;c7 of the ,,support for ,patients and ,community ,act 7,public ,law #aae-bga74